Literature DB >> 23427344

Proportion of neural tube defects attributable to known risk factors.

A J Agopian1, Sarah C Tinker, Philip J Lupo, Mark A Canfield, Laura E Mitchell.   

Abstract

BACKGROUND: Recognized risk factors for neural tube defects (NTDs) poorly predict population-level NTD risk. However, the proportion of NTDs that can be attributed to these risk factors is uncertain.
METHODS: To determine the proportion of NTD cases that is attributable to known or suspected risk factors (i.e., female infant sex, family history of NTDs, and maternal Hispanic ethnicity, obesity, pregestational diabetes, gestational diabetes, low dietary folate intake, lack of folic acid supplementation, anticonvulsant use, and hot tub or sauna use), we estimated the adjusted population attributable fraction (aAF) for each factor, using the method of Eide and Geffler and data from the National Birth Defects Prevention Study.
RESULTS: Our analyses of these data indicate that the proportion of cases of spina bifida and anencephaly that can be attributed to known risk factors is 28% and 44%, respectively. For spina bifida, the factor with the greatest attributable fraction was maternal obesity (aAF, 10%), whereas for anencephaly it was Hispanic ethnicity (aAF, 15%).
CONCLUSION: Our analyses indicate that known risk factors account for <50% of NTD cases. Hence, the majority of NTD cases are attributable to, as yet, unidentified factors. These findings highlight the need for continued research to identify genetic and additional nongenetic risk factors for NTDs. Further, these findings suggest that strategies that aim to reduce the risk of NTDs associated with maternal Hispanic ethnicity and obesity may have the greatest impact on the population prevalence of these conditions.

Entities:  

Mesh:

Year:  2013        PMID: 23427344      PMCID: PMC4482342          DOI: 10.1002/bdra.23100

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  16 in total

Review 1.  Attributable fractions for partitioning risk and evaluating disease prevention: a practical guide.

Authors:  Geir E Eide
Journal:  Clin Respir J       Date:  2008-10       Impact factor: 2.570

2.  Use of antiepileptic medications in pregnancy in relation to risks of birth defects.

Authors:  Martha M Werler; Katherine A Ahrens; Jaclyn L F Bosco; Allen A Mitchell; Marlene T Anderka; Suzanne M Gilboa; Lewis B Holmes
Journal:  Ann Epidemiol       Date:  2011-11       Impact factor: 3.797

3.  The National Birth Defects Prevention Study.

Authors:  P W Yoon; S A Rasmussen; M C Lynberg; C A Moore; M Anderka; S L Carmichael; P Costa; C Druschel; C A Hobbs; P A Romitti; P H Langlois; L D Edmonds
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

4.  Maternal use of hot tub and major structural birth defects.

Authors:  Hao T Duong; Syed Shahrukh Hashmi; Tunu Ramadhani; Mark A Canfield; Angela Scheuerle; Dorothy Kim Waller
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-06-06

5.  Working towards a risk prediction model for neural tube defects.

Authors:  A J Agopian; Philip J Lupo; Sarah C Tinker; Mark A Canfield; Laura E Mitchell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-01-18

6.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Authors:  Bridget S Mosley; Mario A Cleves; Anna Maria Siega-Riz; Gary M Shaw; Mark A Canfield; D Kim Waller; Martha M Werler; Charlotte A Hobbs
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

7.  An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus.

Authors:  Chirag J Patel; Jayanta Bhattacharya; Atul J Butte
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Polytomous logistic regression as a tool for exploring heterogeneity across birth defect subtypes: an example using anencephaly and spina bifida.

Authors:  Philip J Lupo; Elaine Symanski; D Kim Waller; Wenyaw Chan; Mark A Canfield; Peter H Langlois; Laura E Mitchell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-08

9.  Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study.

Authors:  Mark A Canfield; Tunu A Ramadhani; Gary M Shaw; Suzan L Carmichael; D Kim Waller; Bridget S Mosley; Marjorie H Royle; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-07

10.  An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors.

Authors:  Simon Rückinger; Rüdiger von Kries; André Michael Toschke
Journal:  BMC Med Res Methodol       Date:  2009-01-23       Impact factor: 4.615

View more
  32 in total

1.  Folate and neural tube defects: The role of supplements and food fortification.

Authors:  Noam Ami; Mark Bernstein; François Boucher; Michael Rieder; Louise Parker
Journal:  Paediatr Child Health       Date:  2016-04       Impact factor: 2.253

2.  Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population.

Authors:  Na Yang; Linlin Wang; Richard H Finnell; Zhiwen Li; Lei Jin; Le Zhang; Robert M Cabrera; Rongwei Ye; Aiguo Ren
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-05-11

3.  Decreased global DNA hydroxymethylation in neural tube defects: Association with polycyclic aromatic hydrocarbons.

Authors:  Yun Huang; Shanshan Lin; Lei Jin; Linlin Wang; Aiguo Ren
Journal:  Epigenetics       Date:  2019-06-14       Impact factor: 4.528

4.  Proportion of selected congenital heart defects attributable to recognized risk factors.

Authors:  Regina M Simeone; Sarah C Tinker; Suzanne M Gilboa; A J Agopian; Matthew E Oster; Owen J Devine; Margaret A Honein
Journal:  Ann Epidemiol       Date:  2016-10-26       Impact factor: 3.797

5.  Using state and provincial surveillance programs to reduce risk of recurrence of neural tube defects in the United States and Canada: A missed opportunity?

Authors:  Timothy J Flood; Chelsea M Rienks; Alina L Flores; Cara T Mai; Barbara K Frohnert; Rachel E Rutkowski; Jane A Evans; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

6.  Mutations in folate transporter genes and risk for human myelomeningocele.

Authors:  Tina O Findley; Joy C Tenpenny; Michelle R O'Byrne; Alanna C Morrison; James E Hixson; Hope Northrup; Kit Sing Au
Journal:  Am J Med Genet A       Date:  2017-09-26       Impact factor: 2.802

7.  A spectrum project: preterm birth and small-for-gestational age among infants with birth defects.

Authors:  F Miquel-Verges; B S Mosley; A S Block; C A Hobbs
Journal:  J Perinatol       Date:  2014-10-02       Impact factor: 2.521

8.  Global Burden of Neural Tube Defects, Risk Factors, and Prevention.

Authors:  A L Flores; C Vellozzi; D Valencia; J Sniezek
Journal:  Indian J Community Health       Date:  2014-11

9.  Proportion of Orofacial Clefts Attributable to Recognized Risk Factors.

Authors:  Janhavi R Raut; Regina M Simeone; Sarah C Tinker; Mark A Canfield; R Sue Day; A J Agopian
Journal:  Cleft Palate Craniofac J       Date:  2018-05-04

10.  Genetic variations in the GLUT3 gene associated with myelomeningocele.

Authors:  Brendan D Connealy; Hope Northrup; Kit Sing Au
Journal:  Am J Obstet Gynecol       Date:  2014-05-09       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.